nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—systemic lupus erythematosus—Pregabalin—epilepsy syndrome	0.144	0.535	CpDpCtD
Celecoxib—CA4—epilepsy syndrome	0.117	0.609	CbGaD
Celecoxib—systemic lupus erythematosus—Gabapentin—epilepsy syndrome	0.0829	0.307	CpDpCtD
Celecoxib—rheumatoid arthritis—Gabapentin—epilepsy syndrome	0.0428	0.158	CpDpCtD
Celecoxib—CYP2D6—epilepsy syndrome	0.0292	0.151	CbGaD
Celecoxib—PTGS2—epilepsy syndrome	0.0245	0.127	CbGaD
Celecoxib—ALB—epilepsy syndrome	0.0218	0.113	CbGaD
Celecoxib—CA14—Lacosamide—epilepsy syndrome	0.0187	0.0538	CbGbCtD
Celecoxib—CA6—Lacosamide—epilepsy syndrome	0.0177	0.0511	CbGbCtD
Celecoxib—CA5B—Lacosamide—epilepsy syndrome	0.0154	0.0445	CbGbCtD
Celecoxib—CA9—Lacosamide—epilepsy syndrome	0.0133	0.0382	CbGbCtD
Celecoxib—CA14—Acetazolamide—epilepsy syndrome	0.0128	0.037	CbGbCtD
Celecoxib—CA5A—Acetazolamide—epilepsy syndrome	0.0122	0.0352	CbGbCtD
Celecoxib—CA6—Acetazolamide—epilepsy syndrome	0.0122	0.0352	CbGbCtD
Celecoxib—CA14—Zonisamide—epilepsy syndrome	0.0119	0.0343	CbGbCtD
Celecoxib—CA4—Lacosamide—epilepsy syndrome	0.0117	0.0336	CbGbCtD
Celecoxib—CA6—Zonisamide—epilepsy syndrome	0.0113	0.0325	CbGbCtD
Celecoxib—CA5A—Zonisamide—epilepsy syndrome	0.0113	0.0325	CbGbCtD
Celecoxib—CA2—Lacosamide—epilepsy syndrome	0.0107	0.0309	CbGbCtD
Celecoxib—CA5B—Acetazolamide—epilepsy syndrome	0.0106	0.0307	CbGbCtD
Celecoxib—CA5B—Zonisamide—epilepsy syndrome	0.00984	0.0284	CbGbCtD
Celecoxib—CA9—Acetazolamide—epilepsy syndrome	0.00913	0.0263	CbGbCtD
Celecoxib—CA12—Acetazolamide—epilepsy syndrome	0.00913	0.0263	CbGbCtD
Celecoxib—CA9—Zonisamide—epilepsy syndrome	0.00844	0.0243	CbGbCtD
Celecoxib—CA12—Zonisamide—epilepsy syndrome	0.00844	0.0243	CbGbCtD
Celecoxib—CA5A—Topiramate—epilepsy syndrome	0.00823	0.0237	CbGbCtD
Celecoxib—CA6—Topiramate—epilepsy syndrome	0.00823	0.0237	CbGbCtD
Celecoxib—CA4—Acetazolamide—epilepsy syndrome	0.00803	0.0231	CbGbCtD
Celecoxib—CA4—Zonisamide—epilepsy syndrome	0.00743	0.0214	CbGbCtD
Celecoxib—CA2—Acetazolamide—epilepsy syndrome	0.00738	0.0213	CbGbCtD
Celecoxib—CA5B—Topiramate—epilepsy syndrome	0.00717	0.0207	CbGbCtD
Celecoxib—CA2—Zonisamide—epilepsy syndrome	0.00683	0.0197	CbGbCtD
Celecoxib—CA12—Topiramate—epilepsy syndrome	0.00615	0.0177	CbGbCtD
Celecoxib—CA9—Topiramate—epilepsy syndrome	0.00615	0.0177	CbGbCtD
Celecoxib—CA4—Topiramate—epilepsy syndrome	0.00541	0.0156	CbGbCtD
Celecoxib—CA2—Topiramate—epilepsy syndrome	0.00497	0.0143	CbGbCtD
Celecoxib—ALB—Oxcarbazepine—epilepsy syndrome	0.00482	0.0139	CbGbCtD
Celecoxib—ALB—Fosphenytoin—epilepsy syndrome	0.00421	0.0121	CbGbCtD
Celecoxib—ALB—Clonazepam—epilepsy syndrome	0.00381	0.011	CbGbCtD
Celecoxib—ALB—Rufinamide—epilepsy syndrome	0.0031	0.00895	CbGbCtD
Celecoxib—ALB—Phenytoin—epilepsy syndrome	0.00271	0.00782	CbGbCtD
Celecoxib—ALB—Propofol—epilepsy syndrome	0.00253	0.00729	CbGbCtD
Celecoxib—CYP2C9—Trimethadione—epilepsy syndrome	0.00241	0.00696	CbGbCtD
Celecoxib—ALB—Diazepam—epilepsy syndrome	0.00229	0.00661	CbGbCtD
Celecoxib—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00227	0.00654	CbGbCtD
Celecoxib—CA6—ear—epilepsy syndrome	0.00192	0.0903	CbGeAlD
Celecoxib—CYP2C9—Carbamazepine—epilepsy syndrome	0.00163	0.0047	CbGbCtD
Celecoxib—CYP2C9—Primidone—epilepsy syndrome	0.00152	0.00439	CbGbCtD
Celecoxib—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00151	0.00435	CbGbCtD
Celecoxib—CYP2C9—Phenytoin—epilepsy syndrome	0.00146	0.00422	CbGbCtD
Celecoxib—CYP3A4—Trimethadione—epilepsy syndrome	0.0014	0.00405	CbGbCtD
Celecoxib—CYP3A4—Felbamate—epilepsy syndrome	0.0014	0.00405	CbGbCtD
Celecoxib—CYP2C9—Propofol—epilepsy syndrome	0.00136	0.00393	CbGbCtD
Celecoxib—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00132	0.0038	CbGbCtD
Celecoxib—CYP2C9—Phenobarbital—epilepsy syndrome	0.0013	0.00376	CbGbCtD
Celecoxib—CYP2D6—Propofol—epilepsy syndrome	0.00125	0.00359	CbGbCtD
Celecoxib—CYP2C9—Diazepam—epilepsy syndrome	0.00124	0.00356	CbGbCtD
Celecoxib—CYP3A4—Clonazepam—epilepsy syndrome	0.00119	0.00344	CbGbCtD
Celecoxib—CYP3A4—Clobazam—epilepsy syndrome	0.00114	0.0033	CbGbCtD
Celecoxib—CYP2C9—Valproic Acid—epilepsy syndrome	0.000974	0.00281	CbGbCtD
Celecoxib—CYP3A4—Rufinamide—epilepsy syndrome	0.000973	0.0028	CbGbCtD
Celecoxib—CYP3A4—Carbamazepine—epilepsy syndrome	0.000948	0.00273	CbGbCtD
Celecoxib—CYP3A4—Primidone—epilepsy syndrome	0.000885	0.00255	CbGbCtD
Celecoxib—CYP3A4—Phenytoin—epilepsy syndrome	0.00085	0.00245	CbGbCtD
Celecoxib—PDPK1—forebrain—epilepsy syndrome	0.000828	0.0389	CbGeAlD
Celecoxib—MAPK14—hindbrain—epilepsy syndrome	0.0008	0.0376	CbGeAlD
Celecoxib—CYP3A4—Propofol—epilepsy syndrome	0.000793	0.00229	CbGbCtD
Celecoxib—CYP3A4—Phenobarbital—epilepsy syndrome	0.000758	0.00218	CbGbCtD
Celecoxib—CYP3A4—Acetazolamide—epilepsy syndrome	0.000758	0.00218	CbGbCtD
Celecoxib—CYP3A4—Midazolam—epilepsy syndrome	0.000747	0.00215	CbGbCtD
Celecoxib—CYP3A4—Diazepam—epilepsy syndrome	0.000718	0.00207	CbGbCtD
Celecoxib—CYP3A4—Zonisamide—epilepsy syndrome	0.000701	0.00202	CbGbCtD
Celecoxib—PDPK1—medulla oblongata—epilepsy syndrome	0.000598	0.0281	CbGeAlD
Celecoxib—CYP3A4—Valproic Acid—epilepsy syndrome	0.000566	0.00163	CbGbCtD
Celecoxib—PDPK1—midbrain—epilepsy syndrome	0.000546	0.0257	CbGeAlD
Celecoxib—PDPK1—spinal cord—epilepsy syndrome	0.000533	0.0251	CbGeAlD
Celecoxib—CYP3A4—Topiramate—epilepsy syndrome	0.000511	0.00147	CbGbCtD
Celecoxib—CA4—ganglion—epilepsy syndrome	0.000496	0.0233	CbGeAlD
Celecoxib—PDPK1—head—epilepsy syndrome	0.000474	0.0223	CbGeAlD
Celecoxib—MAPK14—brainstem—epilepsy syndrome	0.000459	0.0216	CbGeAlD
Celecoxib—PDPK1—nervous system—epilepsy syndrome	0.000449	0.0211	CbGeAlD
Celecoxib—MAPK14—forebrain—epilepsy syndrome	0.000443	0.0208	CbGeAlD
Celecoxib—PDPK1—central nervous system—epilepsy syndrome	0.000433	0.0203	CbGeAlD
Celecoxib—PDPK1—cerebellum—epilepsy syndrome	0.000423	0.0199	CbGeAlD
Celecoxib—MAPK14—telencephalon—epilepsy syndrome	0.000407	0.0191	CbGeAlD
Celecoxib—CA14—telencephalon—epilepsy syndrome	0.000396	0.0186	CbGeAlD
Celecoxib—CA4—hindbrain—epilepsy syndrome	0.000376	0.0177	CbGeAlD
Celecoxib—PDPK1—brain—epilepsy syndrome	0.000343	0.0162	CbGeAlD
Celecoxib—CA12—forebrain—epilepsy syndrome	0.000336	0.0158	CbGeAlD
Celecoxib—Etoricoxib—CYP2C19—epilepsy syndrome	0.000326	0.358	CrCbGaD
Celecoxib—CA2—hindbrain—epilepsy syndrome	0.000312	0.0147	CbGeAlD
Celecoxib—CA14—medulla oblongata—epilepsy syndrome	0.000311	0.0146	CbGeAlD
Celecoxib—CA12—telencephalon—epilepsy syndrome	0.000309	0.0145	CbGeAlD
Celecoxib—CA6—head—epilepsy syndrome	0.000287	0.0135	CbGeAlD
Celecoxib—MAPK14—spinal cord—epilepsy syndrome	0.000285	0.0134	CbGeAlD
Celecoxib—CA14—midbrain—epilepsy syndrome	0.000284	0.0134	CbGeAlD
Celecoxib—CA14—spinal cord—epilepsy syndrome	0.000277	0.013	CbGeAlD
Celecoxib—MAPK14—head—epilepsy syndrome	0.000253	0.0119	CbGeAlD
Celecoxib—Etoricoxib—CYP2D6—epilepsy syndrome	0.000241	0.266	CrCbGaD
Celecoxib—MAPK14—nervous system—epilepsy syndrome	0.00024	0.0113	CbGeAlD
Celecoxib—CA9—cerebellum—epilepsy syndrome	0.000232	0.0109	CbGeAlD
Celecoxib—MAPK14—central nervous system—epilepsy syndrome	0.000231	0.0109	CbGeAlD
Celecoxib—ABCC4—forebrain—epilepsy syndrome	0.000226	0.0106	CbGeAlD
Celecoxib—MAPK14—cerebellum—epilepsy syndrome	0.000226	0.0106	CbGeAlD
Celecoxib—CA14—cerebellum—epilepsy syndrome	0.00022	0.0103	CbGeAlD
Celecoxib—CA4—brainstem—epilepsy syndrome	0.000215	0.0101	CbGeAlD
Celecoxib—CA4—forebrain—epilepsy syndrome	0.000208	0.00978	CbGeAlD
Celecoxib—Etoricoxib—PTGS2—epilepsy syndrome	0.000203	0.223	CrCbGaD
Celecoxib—CYP2D6—hindbrain—epilepsy syndrome	0.000198	0.00931	CbGeAlD
Celecoxib—CA12—head—epilepsy syndrome	0.000192	0.00904	CbGeAlD
Celecoxib—CA4—telencephalon—epilepsy syndrome	0.000191	0.00899	CbGeAlD
Celecoxib—MAPK14—brain—epilepsy syndrome	0.000184	0.00864	CbGeAlD
Celecoxib—CA12—nervous system—epilepsy syndrome	0.000182	0.00857	CbGeAlD
Celecoxib—CA14—brain—epilepsy syndrome	0.000179	0.0084	CbGeAlD
Celecoxib—CA2—brainstem—epilepsy syndrome	0.000179	0.0084	CbGeAlD
Celecoxib—CA12—central nervous system—epilepsy syndrome	0.000175	0.00826	CbGeAlD
Celecoxib—CA5B—head—epilepsy syndrome	0.000172	0.00811	CbGeAlD
Celecoxib—CA2—forebrain—epilepsy syndrome	0.000172	0.00811	CbGeAlD
Celecoxib—ORM1—spinal cord—epilepsy syndrome	0.000172	0.00808	CbGeAlD
Celecoxib—CA5B—nervous system—epilepsy syndrome	0.000164	0.00769	CbGeAlD
Celecoxib—CA2—telencephalon—epilepsy syndrome	0.000159	0.00746	CbGeAlD
Celecoxib—CA5B—central nervous system—epilepsy syndrome	0.000157	0.00741	CbGeAlD
Celecoxib—CA4—medulla oblongata—epilepsy syndrome	0.00015	0.00707	CbGeAlD
Celecoxib—ORM1—nervous system—epilepsy syndrome	0.000145	0.0068	CbGeAlD
Celecoxib—CA12—brain—epilepsy syndrome	0.000139	0.00655	CbGeAlD
Celecoxib—ORM1—central nervous system—epilepsy syndrome	0.000139	0.00655	CbGeAlD
Celecoxib—Sulfaphenazole—CYP2D6—epilepsy syndrome	0.000139	0.153	CrCbGaD
Celecoxib—CA4—midbrain—epilepsy syndrome	0.000137	0.00646	CbGeAlD
Celecoxib—CA4—spinal cord—epilepsy syndrome	0.000134	0.0063	CbGeAlD
Celecoxib—ABCC4—head—epilepsy syndrome	0.00013	0.00609	CbGeAlD
Celecoxib—PTGS2—forebrain—epilepsy syndrome	0.000127	0.00599	CbGeAlD
Celecoxib—CA5B—brain—epilepsy syndrome	0.000125	0.00588	CbGeAlD
Celecoxib—CA2—medulla oblongata—epilepsy syndrome	0.000125	0.00586	CbGeAlD
Celecoxib—ABCC4—nervous system—epilepsy syndrome	0.000123	0.00578	CbGeAlD
Celecoxib—CA4—head—epilepsy syndrome	0.000119	0.0056	CbGeAlD
Celecoxib—ABCC4—central nervous system—epilepsy syndrome	0.000118	0.00556	CbGeAlD
Celecoxib—PTGS2—telencephalon—epilepsy syndrome	0.000117	0.00551	CbGeAlD
Celecoxib—CA2—midbrain—epilepsy syndrome	0.000114	0.00536	CbGeAlD
Celecoxib—CYP2D6—brainstem—epilepsy syndrome	0.000113	0.00533	CbGeAlD
Celecoxib—CA4—nervous system—epilepsy syndrome	0.000113	0.00531	CbGeAlD
Celecoxib—CA2—spinal cord—epilepsy syndrome	0.000111	0.00522	CbGeAlD
Celecoxib—CYP2D6—forebrain—epilepsy syndrome	0.000109	0.00515	CbGeAlD
Celecoxib—CA4—central nervous system—epilepsy syndrome	0.000109	0.00511	CbGeAlD
Celecoxib—CA4—cerebellum—epilepsy syndrome	0.000106	0.005	CbGeAlD
Celecoxib—CYP2D6—telencephalon—epilepsy syndrome	0.000101	0.00473	CbGeAlD
Celecoxib—CA2—head—epilepsy syndrome	9.87e-05	0.00464	CbGeAlD
Celecoxib—ALB—brain—epilepsy syndrome	9.7e-05	0.00456	CbGeAlD
Celecoxib—ABCC4—brain—epilepsy syndrome	9.38e-05	0.00441	CbGeAlD
Celecoxib—CA2—nervous system—epilepsy syndrome	9.36e-05	0.0044	CbGeAlD
Celecoxib—PTGS2—medulla oblongata—epilepsy syndrome	9.2e-05	0.00433	CbGeAlD
Celecoxib—CA2—central nervous system—epilepsy syndrome	9.01e-05	0.00424	CbGeAlD
Celecoxib—CA2—cerebellum—epilepsy syndrome	8.81e-05	0.00414	CbGeAlD
Celecoxib—CA4—brain—epilepsy syndrome	8.63e-05	0.00406	CbGeAlD
Celecoxib—PTGS2—midbrain—epilepsy syndrome	8.4e-05	0.00395	CbGeAlD
Celecoxib—PTGS2—spinal cord—epilepsy syndrome	8.2e-05	0.00386	CbGeAlD
Celecoxib—PTGS2—head—epilepsy syndrome	7.29e-05	0.00343	CbGeAlD
Celecoxib—CA2—brain—epilepsy syndrome	7.15e-05	0.00336	CbGeAlD
Celecoxib—PTGS2—nervous system—epilepsy syndrome	6.91e-05	0.00325	CbGeAlD
Celecoxib—PTGS2—central nervous system—epilepsy syndrome	6.65e-05	0.00313	CbGeAlD
Celecoxib—PTGS2—cerebellum—epilepsy syndrome	6.5e-05	0.00306	CbGeAlD
Celecoxib—CYP2D6—head—epilepsy syndrome	6.27e-05	0.00295	CbGeAlD
Celecoxib—CYP3A4—nervous system—epilepsy syndrome	6.04e-05	0.00284	CbGeAlD
Celecoxib—CYP2D6—nervous system—epilepsy syndrome	5.94e-05	0.00279	CbGeAlD
Celecoxib—CYP3A4—central nervous system—epilepsy syndrome	5.81e-05	0.00273	CbGeAlD
Celecoxib—CYP2D6—central nervous system—epilepsy syndrome	5.72e-05	0.00269	CbGeAlD
Celecoxib—CYP2D6—cerebellum—epilepsy syndrome	5.59e-05	0.00263	CbGeAlD
Celecoxib—PTGS2—brain—epilepsy syndrome	5.28e-05	0.00248	CbGeAlD
Celecoxib—CYP2D6—brain—epilepsy syndrome	4.54e-05	0.00214	CbGeAlD
Celecoxib—Dizziness—Felbamate—epilepsy syndrome	1.51e-05	0.000149	CcSEcCtD
Celecoxib—Dermatitis—Vigabatrin—epilepsy syndrome	1.51e-05	0.000149	CcSEcCtD
Celecoxib—Urethral disorder—Topiramate—epilepsy syndrome	1.51e-05	0.000149	CcSEcCtD
Celecoxib—Pruritus—Oxcarbazepine—epilepsy syndrome	1.5e-05	0.000148	CcSEcCtD
Celecoxib—Hypersensitivity—Carbamazepine—epilepsy syndrome	1.5e-05	0.000148	CcSEcCtD
Celecoxib—Vision blurred—Gabapentin—epilepsy syndrome	1.5e-05	0.000148	CcSEcCtD
Celecoxib—Headache—Vigabatrin—epilepsy syndrome	1.5e-05	0.000148	CcSEcCtD
Celecoxib—Hypertension—Pregabalin—epilepsy syndrome	1.5e-05	0.000148	CcSEcCtD
Celecoxib—Vomiting—Diazepam—epilepsy syndrome	1.5e-05	0.000148	CcSEcCtD
Celecoxib—Anorexia—Valproic Acid—epilepsy syndrome	1.49e-05	0.000147	CcSEcCtD
Celecoxib—Rash—Diazepam—epilepsy syndrome	1.49e-05	0.000147	CcSEcCtD
Celecoxib—Dermatitis—Diazepam—epilepsy syndrome	1.48e-05	0.000146	CcSEcCtD
Celecoxib—Chest pain—Pregabalin—epilepsy syndrome	1.48e-05	0.000146	CcSEcCtD
Celecoxib—Arthralgia—Pregabalin—epilepsy syndrome	1.48e-05	0.000146	CcSEcCtD
Celecoxib—Myalgia—Pregabalin—epilepsy syndrome	1.48e-05	0.000146	CcSEcCtD
Celecoxib—Dizziness—Zonisamide—epilepsy syndrome	1.48e-05	0.000146	CcSEcCtD
Celecoxib—Headache—Diazepam—epilepsy syndrome	1.48e-05	0.000146	CcSEcCtD
Celecoxib—Anxiety—Pregabalin—epilepsy syndrome	1.47e-05	0.000145	CcSEcCtD
Celecoxib—Diarrhoea—Clonazepam—epilepsy syndrome	1.47e-05	0.000145	CcSEcCtD
Celecoxib—Anaemia—Gabapentin—epilepsy syndrome	1.47e-05	0.000145	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	1.47e-05	0.000145	CcSEcCtD
Celecoxib—Asthenia—Carbamazepine—epilepsy syndrome	1.46e-05	0.000144	CcSEcCtD
Celecoxib—Diarrhoea—Phenytoin—epilepsy syndrome	1.46e-05	0.000144	CcSEcCtD
Celecoxib—Nausea—Fosphenytoin—epilepsy syndrome	1.46e-05	0.000144	CcSEcCtD
Celecoxib—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.45e-05	0.000143	CcSEcCtD
Celecoxib—Erythema multiforme—Topiramate—epilepsy syndrome	1.45e-05	0.000143	CcSEcCtD
Celecoxib—Angioedema—Gabapentin—epilepsy syndrome	1.45e-05	0.000143	CcSEcCtD
Celecoxib—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.45e-05	0.000143	CcSEcCtD
Celecoxib—Vomiting—Felbamate—epilepsy syndrome	1.45e-05	0.000143	CcSEcCtD
Celecoxib—Dry mouth—Pregabalin—epilepsy syndrome	1.45e-05	0.000142	CcSEcCtD
Celecoxib—Pruritus—Carbamazepine—epilepsy syndrome	1.44e-05	0.000142	CcSEcCtD
Celecoxib—Rash—Felbamate—epilepsy syndrome	1.44e-05	0.000142	CcSEcCtD
Celecoxib—Eye disorder—Topiramate—epilepsy syndrome	1.44e-05	0.000142	CcSEcCtD
Celecoxib—Dermatitis—Felbamate—epilepsy syndrome	1.44e-05	0.000142	CcSEcCtD
Celecoxib—Tinnitus—Topiramate—epilepsy syndrome	1.43e-05	0.000141	CcSEcCtD
Celecoxib—Vertigo—Gabapentin—epilepsy syndrome	1.43e-05	0.000141	CcSEcCtD
Celecoxib—Headache—Felbamate—epilepsy syndrome	1.43e-05	0.000141	CcSEcCtD
Celecoxib—Confusional state—Pregabalin—epilepsy syndrome	1.43e-05	0.000141	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.43e-05	0.000141	CcSEcCtD
Celecoxib—Flushing—Topiramate—epilepsy syndrome	1.43e-05	0.000141	CcSEcCtD
Celecoxib—Cardiac disorder—Topiramate—epilepsy syndrome	1.43e-05	0.000141	CcSEcCtD
Celecoxib—Syncope—Gabapentin—epilepsy syndrome	1.43e-05	0.000141	CcSEcCtD
Celecoxib—Leukopenia—Gabapentin—epilepsy syndrome	1.42e-05	0.00014	CcSEcCtD
Celecoxib—Dizziness—Clonazepam—epilepsy syndrome	1.42e-05	0.00014	CcSEcCtD
Celecoxib—Nausea—Vigabatrin—epilepsy syndrome	1.42e-05	0.00014	CcSEcCtD
Celecoxib—Vomiting—Zonisamide—epilepsy syndrome	1.42e-05	0.00014	CcSEcCtD
Celecoxib—Insomnia—Valproic Acid—epilepsy syndrome	1.42e-05	0.00014	CcSEcCtD
Celecoxib—Anaphylactic shock—Pregabalin—epilepsy syndrome	1.42e-05	0.00014	CcSEcCtD
Celecoxib—Oedema—Pregabalin—epilepsy syndrome	1.42e-05	0.00014	CcSEcCtD
Celecoxib—Asthenia—Lamotrigine—epilepsy syndrome	1.41e-05	0.000139	CcSEcCtD
Celecoxib—Dizziness—Phenytoin—epilepsy syndrome	1.41e-05	0.000139	CcSEcCtD
Celecoxib—Rash—Zonisamide—epilepsy syndrome	1.41e-05	0.000139	CcSEcCtD
Celecoxib—Infection—Pregabalin—epilepsy syndrome	1.41e-05	0.000139	CcSEcCtD
Celecoxib—Paraesthesia—Valproic Acid—epilepsy syndrome	1.41e-05	0.000139	CcSEcCtD
Celecoxib—Palpitations—Gabapentin—epilepsy syndrome	1.41e-05	0.000139	CcSEcCtD
Celecoxib—Dermatitis—Zonisamide—epilepsy syndrome	1.41e-05	0.000139	CcSEcCtD
Celecoxib—Dizziness—Oxcarbazepine—epilepsy syndrome	1.41e-05	0.000139	CcSEcCtD
Celecoxib—Nausea—Diazepam—epilepsy syndrome	1.4e-05	0.000138	CcSEcCtD
Celecoxib—Loss of consciousness—Gabapentin—epilepsy syndrome	1.4e-05	0.000138	CcSEcCtD
Celecoxib—Headache—Zonisamide—epilepsy syndrome	1.4e-05	0.000138	CcSEcCtD
Celecoxib—Dyspnoea—Valproic Acid—epilepsy syndrome	1.4e-05	0.000138	CcSEcCtD
Celecoxib—Diarrhoea—Carbamazepine—epilepsy syndrome	1.4e-05	0.000138	CcSEcCtD
Celecoxib—Angiopathy—Topiramate—epilepsy syndrome	1.4e-05	0.000138	CcSEcCtD
Celecoxib—Pruritus—Lamotrigine—epilepsy syndrome	1.4e-05	0.000138	CcSEcCtD
Celecoxib—Shock—Pregabalin—epilepsy syndrome	1.39e-05	0.000137	CcSEcCtD
Celecoxib—Somnolence—Valproic Acid—epilepsy syndrome	1.39e-05	0.000137	CcSEcCtD
Celecoxib—Immune system disorder—Topiramate—epilepsy syndrome	1.39e-05	0.000137	CcSEcCtD
Celecoxib—Nervous system disorder—Pregabalin—epilepsy syndrome	1.39e-05	0.000137	CcSEcCtD
Celecoxib—Cough—Gabapentin—epilepsy syndrome	1.39e-05	0.000137	CcSEcCtD
Celecoxib—Thrombocytopenia—Pregabalin—epilepsy syndrome	1.39e-05	0.000137	CcSEcCtD
Celecoxib—Mediastinal disorder—Topiramate—epilepsy syndrome	1.39e-05	0.000137	CcSEcCtD
Celecoxib—Tachycardia—Pregabalin—epilepsy syndrome	1.38e-05	0.000136	CcSEcCtD
Celecoxib—Dyspepsia—Valproic Acid—epilepsy syndrome	1.38e-05	0.000136	CcSEcCtD
Celecoxib—Skin disorder—Pregabalin—epilepsy syndrome	1.38e-05	0.000136	CcSEcCtD
Celecoxib—Hypertension—Gabapentin—epilepsy syndrome	1.37e-05	0.000135	CcSEcCtD
Celecoxib—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.37e-05	0.000135	CcSEcCtD
Celecoxib—Vomiting—Clonazepam—epilepsy syndrome	1.37e-05	0.000135	CcSEcCtD
Celecoxib—Decreased appetite—Valproic Acid—epilepsy syndrome	1.36e-05	0.000134	CcSEcCtD
Celecoxib—Alopecia—Topiramate—epilepsy syndrome	1.36e-05	0.000134	CcSEcCtD
Celecoxib—Vomiting—Phenytoin—epilepsy syndrome	1.36e-05	0.000134	CcSEcCtD
Celecoxib—Rash—Clonazepam—epilepsy syndrome	1.36e-05	0.000134	CcSEcCtD
Celecoxib—Dermatitis—Clonazepam—epilepsy syndrome	1.36e-05	0.000134	CcSEcCtD
Celecoxib—Arthralgia—Gabapentin—epilepsy syndrome	1.36e-05	0.000134	CcSEcCtD
Celecoxib—Myalgia—Gabapentin—epilepsy syndrome	1.36e-05	0.000134	CcSEcCtD
Celecoxib—Chest pain—Gabapentin—epilepsy syndrome	1.36e-05	0.000134	CcSEcCtD
Celecoxib—Nausea—Felbamate—epilepsy syndrome	1.35e-05	0.000134	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.35e-05	0.000133	CcSEcCtD
Celecoxib—Vomiting—Oxcarbazepine—epilepsy syndrome	1.35e-05	0.000133	CcSEcCtD
Celecoxib—Fatigue—Valproic Acid—epilepsy syndrome	1.35e-05	0.000133	CcSEcCtD
Celecoxib—Anxiety—Gabapentin—epilepsy syndrome	1.35e-05	0.000133	CcSEcCtD
Celecoxib—Anorexia—Pregabalin—epilepsy syndrome	1.35e-05	0.000133	CcSEcCtD
Celecoxib—Dizziness—Carbamazepine—epilepsy syndrome	1.35e-05	0.000133	CcSEcCtD
Celecoxib—Diarrhoea—Lamotrigine—epilepsy syndrome	1.35e-05	0.000133	CcSEcCtD
Celecoxib—Headache—Clonazepam—epilepsy syndrome	1.35e-05	0.000133	CcSEcCtD
Celecoxib—Rash—Phenytoin—epilepsy syndrome	1.35e-05	0.000133	CcSEcCtD
Celecoxib—Mental disorder—Topiramate—epilepsy syndrome	1.35e-05	0.000133	CcSEcCtD
Celecoxib—Dermatitis—Phenytoin—epilepsy syndrome	1.35e-05	0.000133	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.35e-05	0.000133	CcSEcCtD
Celecoxib—Rash—Oxcarbazepine—epilepsy syndrome	1.34e-05	0.000132	CcSEcCtD
Celecoxib—Constipation—Valproic Acid—epilepsy syndrome	1.34e-05	0.000132	CcSEcCtD
Celecoxib—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.34e-05	0.000132	CcSEcCtD
Celecoxib—Headache—Phenytoin—epilepsy syndrome	1.34e-05	0.000132	CcSEcCtD
Celecoxib—Headache—Oxcarbazepine—epilepsy syndrome	1.33e-05	0.000131	CcSEcCtD
Celecoxib—Nausea—Zonisamide—epilepsy syndrome	1.33e-05	0.000131	CcSEcCtD
Celecoxib—Dry mouth—Gabapentin—epilepsy syndrome	1.33e-05	0.000131	CcSEcCtD
Celecoxib—Flatulence—Topiramate—epilepsy syndrome	1.32e-05	0.00013	CcSEcCtD
Celecoxib—Tension—Topiramate—epilepsy syndrome	1.31e-05	0.00013	CcSEcCtD
Celecoxib—Dysgeusia—Topiramate—epilepsy syndrome	1.31e-05	0.000129	CcSEcCtD
Celecoxib—Confusional state—Gabapentin—epilepsy syndrome	1.31e-05	0.000129	CcSEcCtD
Celecoxib—Dizziness—Lamotrigine—epilepsy syndrome	1.3e-05	0.000129	CcSEcCtD
Celecoxib—Nervousness—Topiramate—epilepsy syndrome	1.3e-05	0.000128	CcSEcCtD
Celecoxib—Oedema—Gabapentin—epilepsy syndrome	1.3e-05	0.000128	CcSEcCtD
Celecoxib—Anaphylactic shock—Gabapentin—epilepsy syndrome	1.3e-05	0.000128	CcSEcCtD
Celecoxib—Vomiting—Carbamazepine—epilepsy syndrome	1.3e-05	0.000128	CcSEcCtD
Celecoxib—Back pain—Topiramate—epilepsy syndrome	1.3e-05	0.000128	CcSEcCtD
Celecoxib—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.29e-05	0.000127	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.29e-05	0.000127	CcSEcCtD
Celecoxib—Infection—Gabapentin—epilepsy syndrome	1.29e-05	0.000127	CcSEcCtD
Celecoxib—Muscle spasms—Topiramate—epilepsy syndrome	1.29e-05	0.000127	CcSEcCtD
Celecoxib—Rash—Carbamazepine—epilepsy syndrome	1.29e-05	0.000127	CcSEcCtD
Celecoxib—Dermatitis—Carbamazepine—epilepsy syndrome	1.29e-05	0.000127	CcSEcCtD
Celecoxib—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.28e-05	0.000126	CcSEcCtD
Celecoxib—Insomnia—Pregabalin—epilepsy syndrome	1.28e-05	0.000126	CcSEcCtD
Celecoxib—Nausea—Clonazepam—epilepsy syndrome	1.28e-05	0.000126	CcSEcCtD
Celecoxib—Headache—Carbamazepine—epilepsy syndrome	1.28e-05	0.000126	CcSEcCtD
Celecoxib—Shock—Gabapentin—epilepsy syndrome	1.28e-05	0.000126	CcSEcCtD
Celecoxib—Nervous system disorder—Gabapentin—epilepsy syndrome	1.27e-05	0.000126	CcSEcCtD
Celecoxib—Paraesthesia—Pregabalin—epilepsy syndrome	1.27e-05	0.000125	CcSEcCtD
Celecoxib—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.27e-05	0.000125	CcSEcCtD
Celecoxib—Nausea—Phenytoin—epilepsy syndrome	1.27e-05	0.000125	CcSEcCtD
Celecoxib—Tachycardia—Gabapentin—epilepsy syndrome	1.27e-05	0.000125	CcSEcCtD
Celecoxib—Dyspnoea—Pregabalin—epilepsy syndrome	1.26e-05	0.000125	CcSEcCtD
Celecoxib—Nausea—Oxcarbazepine—epilepsy syndrome	1.26e-05	0.000125	CcSEcCtD
Celecoxib—Vision blurred—Topiramate—epilepsy syndrome	1.26e-05	0.000124	CcSEcCtD
Celecoxib—Skin disorder—Gabapentin—epilepsy syndrome	1.26e-05	0.000124	CcSEcCtD
Celecoxib—Somnolence—Pregabalin—epilepsy syndrome	1.26e-05	0.000124	CcSEcCtD
Celecoxib—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.26e-05	0.000124	CcSEcCtD
Celecoxib—Vomiting—Lamotrigine—epilepsy syndrome	1.25e-05	0.000124	CcSEcCtD
Celecoxib—Urticaria—Valproic Acid—epilepsy syndrome	1.24e-05	0.000123	CcSEcCtD
Celecoxib—Rash—Lamotrigine—epilepsy syndrome	1.24e-05	0.000123	CcSEcCtD
Celecoxib—Dermatitis—Lamotrigine—epilepsy syndrome	1.24e-05	0.000122	CcSEcCtD
Celecoxib—Abdominal pain—Valproic Acid—epilepsy syndrome	1.24e-05	0.000122	CcSEcCtD
Celecoxib—Body temperature increased—Valproic Acid—epilepsy syndrome	1.24e-05	0.000122	CcSEcCtD
Celecoxib—Anorexia—Gabapentin—epilepsy syndrome	1.24e-05	0.000122	CcSEcCtD
Celecoxib—Anaemia—Topiramate—epilepsy syndrome	1.24e-05	0.000122	CcSEcCtD
Celecoxib—Headache—Lamotrigine—epilepsy syndrome	1.24e-05	0.000122	CcSEcCtD
Celecoxib—Decreased appetite—Pregabalin—epilepsy syndrome	1.23e-05	0.000121	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.22e-05	0.000121	CcSEcCtD
Celecoxib—Fatigue—Pregabalin—epilepsy syndrome	1.22e-05	0.00012	CcSEcCtD
Celecoxib—Nausea—Carbamazepine—epilepsy syndrome	1.21e-05	0.000119	CcSEcCtD
Celecoxib—Constipation—Pregabalin—epilepsy syndrome	1.21e-05	0.000119	CcSEcCtD
Celecoxib—Vertigo—Topiramate—epilepsy syndrome	1.2e-05	0.000119	CcSEcCtD
Celecoxib—Syncope—Topiramate—epilepsy syndrome	1.2e-05	0.000118	CcSEcCtD
Celecoxib—Leukopenia—Topiramate—epilepsy syndrome	1.2e-05	0.000118	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.18e-05	0.000117	CcSEcCtD
Celecoxib—Palpitations—Topiramate—epilepsy syndrome	1.18e-05	0.000117	CcSEcCtD
Celecoxib—Loss of consciousness—Topiramate—epilepsy syndrome	1.18e-05	0.000116	CcSEcCtD
Celecoxib—Insomnia—Gabapentin—epilepsy syndrome	1.17e-05	0.000116	CcSEcCtD
Celecoxib—Nausea—Lamotrigine—epilepsy syndrome	1.17e-05	0.000115	CcSEcCtD
Celecoxib—Cough—Topiramate—epilepsy syndrome	1.17e-05	0.000115	CcSEcCtD
Celecoxib—Feeling abnormal—Pregabalin—epilepsy syndrome	1.17e-05	0.000115	CcSEcCtD
Celecoxib—Paraesthesia—Gabapentin—epilepsy syndrome	1.17e-05	0.000115	CcSEcCtD
Celecoxib—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.16e-05	0.000114	CcSEcCtD
Celecoxib—Dyspnoea—Gabapentin—epilepsy syndrome	1.16e-05	0.000114	CcSEcCtD
Celecoxib—Hypertension—Topiramate—epilepsy syndrome	1.16e-05	0.000114	CcSEcCtD
Celecoxib—Somnolence—Gabapentin—epilepsy syndrome	1.15e-05	0.000114	CcSEcCtD
Celecoxib—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.15e-05	0.000114	CcSEcCtD
Celecoxib—Dyspepsia—Gabapentin—epilepsy syndrome	1.14e-05	0.000113	CcSEcCtD
Celecoxib—Myalgia—Topiramate—epilepsy syndrome	1.14e-05	0.000112	CcSEcCtD
Celecoxib—Chest pain—Topiramate—epilepsy syndrome	1.14e-05	0.000112	CcSEcCtD
Celecoxib—Arthralgia—Topiramate—epilepsy syndrome	1.14e-05	0.000112	CcSEcCtD
Celecoxib—Anxiety—Topiramate—epilepsy syndrome	1.14e-05	0.000112	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.13e-05	0.000112	CcSEcCtD
Celecoxib—Decreased appetite—Gabapentin—epilepsy syndrome	1.13e-05	0.000111	CcSEcCtD
Celecoxib—Urticaria—Pregabalin—epilepsy syndrome	1.13e-05	0.000111	CcSEcCtD
Celecoxib—Asthenia—Valproic Acid—epilepsy syndrome	1.12e-05	0.000111	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.12e-05	0.000111	CcSEcCtD
Celecoxib—Fatigue—Gabapentin—epilepsy syndrome	1.12e-05	0.00011	CcSEcCtD
Celecoxib—Body temperature increased—Pregabalin—epilepsy syndrome	1.12e-05	0.00011	CcSEcCtD
Celecoxib—Abdominal pain—Pregabalin—epilepsy syndrome	1.12e-05	0.00011	CcSEcCtD
Celecoxib—Dry mouth—Topiramate—epilepsy syndrome	1.11e-05	0.00011	CcSEcCtD
Celecoxib—Constipation—Gabapentin—epilepsy syndrome	1.11e-05	0.00011	CcSEcCtD
Celecoxib—Pruritus—Valproic Acid—epilepsy syndrome	1.11e-05	0.000109	CcSEcCtD
Celecoxib—Confusional state—Topiramate—epilepsy syndrome	1.1e-05	0.000109	CcSEcCtD
Celecoxib—Oedema—Topiramate—epilepsy syndrome	1.09e-05	0.000108	CcSEcCtD
Celecoxib—Infection—Topiramate—epilepsy syndrome	1.09e-05	0.000107	CcSEcCtD
Celecoxib—Shock—Topiramate—epilepsy syndrome	1.08e-05	0.000106	CcSEcCtD
Celecoxib—Diarrhoea—Valproic Acid—epilepsy syndrome	1.07e-05	0.000106	CcSEcCtD
Celecoxib—Nervous system disorder—Topiramate—epilepsy syndrome	1.07e-05	0.000106	CcSEcCtD
Celecoxib—Feeling abnormal—Gabapentin—epilepsy syndrome	1.07e-05	0.000106	CcSEcCtD
Celecoxib—Thrombocytopenia—Topiramate—epilepsy syndrome	1.07e-05	0.000106	CcSEcCtD
Celecoxib—Tachycardia—Topiramate—epilepsy syndrome	1.07e-05	0.000105	CcSEcCtD
Celecoxib—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.06e-05	0.000105	CcSEcCtD
Celecoxib—Skin disorder—Topiramate—epilepsy syndrome	1.06e-05	0.000105	CcSEcCtD
Celecoxib—Hyperhidrosis—Topiramate—epilepsy syndrome	1.06e-05	0.000104	CcSEcCtD
Celecoxib—Hypersensitivity—Pregabalin—epilepsy syndrome	1.04e-05	0.000103	CcSEcCtD
Celecoxib—Anorexia—Topiramate—epilepsy syndrome	1.04e-05	0.000103	CcSEcCtD
Celecoxib—Dizziness—Valproic Acid—epilepsy syndrome	1.04e-05	0.000102	CcSEcCtD
Celecoxib—Urticaria—Gabapentin—epilepsy syndrome	1.03e-05	0.000102	CcSEcCtD
Celecoxib—Body temperature increased—Gabapentin—epilepsy syndrome	1.03e-05	0.000101	CcSEcCtD
Celecoxib—Abdominal pain—Gabapentin—epilepsy syndrome	1.03e-05	0.000101	CcSEcCtD
Celecoxib—Asthenia—Pregabalin—epilepsy syndrome	1.02e-05	0.0001	CcSEcCtD
Celecoxib—Pruritus—Pregabalin—epilepsy syndrome	1e-05	9.88e-05	CcSEcCtD
Celecoxib—Vomiting—Valproic Acid—epilepsy syndrome	9.96e-06	9.82e-05	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	9.96e-06	9.82e-05	CcSEcCtD
Celecoxib—Insomnia—Topiramate—epilepsy syndrome	9.88e-06	9.75e-05	CcSEcCtD
Celecoxib—Rash—Valproic Acid—epilepsy syndrome	9.88e-06	9.74e-05	CcSEcCtD
Celecoxib—Dermatitis—Valproic Acid—epilepsy syndrome	9.87e-06	9.73e-05	CcSEcCtD
Celecoxib—Headache—Valproic Acid—epilepsy syndrome	9.82e-06	9.68e-05	CcSEcCtD
Celecoxib—Paraesthesia—Topiramate—epilepsy syndrome	9.81e-06	9.68e-05	CcSEcCtD
Celecoxib—Dyspnoea—Topiramate—epilepsy syndrome	9.74e-06	9.61e-05	CcSEcCtD
Celecoxib—Somnolence—Topiramate—epilepsy syndrome	9.72e-06	9.58e-05	CcSEcCtD
Celecoxib—Diarrhoea—Pregabalin—epilepsy syndrome	9.69e-06	9.56e-05	CcSEcCtD
Celecoxib—Dyspepsia—Topiramate—epilepsy syndrome	9.62e-06	9.48e-05	CcSEcCtD
Celecoxib—Hypersensitivity—Gabapentin—epilepsy syndrome	9.57e-06	9.44e-05	CcSEcCtD
Celecoxib—Decreased appetite—Topiramate—epilepsy syndrome	9.5e-06	9.37e-05	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Topiramate—epilepsy syndrome	9.44e-06	9.3e-05	CcSEcCtD
Celecoxib—Fatigue—Topiramate—epilepsy syndrome	9.42e-06	9.29e-05	CcSEcCtD
Celecoxib—Dizziness—Pregabalin—epilepsy syndrome	9.37e-06	9.24e-05	CcSEcCtD
Celecoxib—Constipation—Topiramate—epilepsy syndrome	9.35e-06	9.21e-05	CcSEcCtD
Celecoxib—Asthenia—Gabapentin—epilepsy syndrome	9.32e-06	9.19e-05	CcSEcCtD
Celecoxib—Nausea—Valproic Acid—epilepsy syndrome	9.31e-06	9.18e-05	CcSEcCtD
Celecoxib—Pruritus—Gabapentin—epilepsy syndrome	9.19e-06	9.06e-05	CcSEcCtD
Celecoxib—Vomiting—Pregabalin—epilepsy syndrome	9.01e-06	8.88e-05	CcSEcCtD
Celecoxib—Feeling abnormal—Topiramate—epilepsy syndrome	9.01e-06	8.88e-05	CcSEcCtD
Celecoxib—Gastrointestinal pain—Topiramate—epilepsy syndrome	8.94e-06	8.81e-05	CcSEcCtD
Celecoxib—Rash—Pregabalin—epilepsy syndrome	8.93e-06	8.81e-05	CcSEcCtD
Celecoxib—Dermatitis—Pregabalin—epilepsy syndrome	8.92e-06	8.8e-05	CcSEcCtD
Celecoxib—Diarrhoea—Gabapentin—epilepsy syndrome	8.89e-06	8.76e-05	CcSEcCtD
Celecoxib—Headache—Pregabalin—epilepsy syndrome	8.87e-06	8.75e-05	CcSEcCtD
Celecoxib—Urticaria—Topiramate—epilepsy syndrome	8.68e-06	8.56e-05	CcSEcCtD
Celecoxib—Abdominal pain—Topiramate—epilepsy syndrome	8.64e-06	8.52e-05	CcSEcCtD
Celecoxib—Body temperature increased—Topiramate—epilepsy syndrome	8.64e-06	8.52e-05	CcSEcCtD
Celecoxib—Dizziness—Gabapentin—epilepsy syndrome	8.59e-06	8.47e-05	CcSEcCtD
Celecoxib—Nausea—Pregabalin—epilepsy syndrome	8.41e-06	8.3e-05	CcSEcCtD
Celecoxib—Vomiting—Gabapentin—epilepsy syndrome	8.26e-06	8.14e-05	CcSEcCtD
Celecoxib—Rash—Gabapentin—epilepsy syndrome	8.19e-06	8.08e-05	CcSEcCtD
Celecoxib—Dermatitis—Gabapentin—epilepsy syndrome	8.18e-06	8.07e-05	CcSEcCtD
Celecoxib—Headache—Gabapentin—epilepsy syndrome	8.14e-06	8.02e-05	CcSEcCtD
Celecoxib—Hypersensitivity—Topiramate—epilepsy syndrome	8.05e-06	7.94e-05	CcSEcCtD
Celecoxib—Asthenia—Topiramate—epilepsy syndrome	7.84e-06	7.73e-05	CcSEcCtD
Celecoxib—Pruritus—Topiramate—epilepsy syndrome	7.73e-06	7.62e-05	CcSEcCtD
Celecoxib—Nausea—Gabapentin—epilepsy syndrome	7.72e-06	7.61e-05	CcSEcCtD
Celecoxib—Diarrhoea—Topiramate—epilepsy syndrome	7.48e-06	7.37e-05	CcSEcCtD
Celecoxib—Dizziness—Topiramate—epilepsy syndrome	7.23e-06	7.13e-05	CcSEcCtD
Celecoxib—Vomiting—Topiramate—epilepsy syndrome	6.95e-06	6.85e-05	CcSEcCtD
Celecoxib—Rash—Topiramate—epilepsy syndrome	6.89e-06	6.79e-05	CcSEcCtD
Celecoxib—Dermatitis—Topiramate—epilepsy syndrome	6.88e-06	6.79e-05	CcSEcCtD
Celecoxib—Headache—Topiramate—epilepsy syndrome	6.85e-06	6.75e-05	CcSEcCtD
Celecoxib—Nausea—Topiramate—epilepsy syndrome	6.49e-06	6.4e-05	CcSEcCtD
Celecoxib—MAPK14—Signaling Pathways—CNR1—epilepsy syndrome	1.57e-06	2.34e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—JUNB—epilepsy syndrome	1.57e-06	2.34e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PLCB1—epilepsy syndrome	1.56e-06	2.34e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GLUL—epilepsy syndrome	1.55e-06	2.32e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ALB—epilepsy syndrome	1.54e-06	2.31e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—PLAU—epilepsy syndrome	1.54e-06	2.3e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GLUL—epilepsy syndrome	1.54e-06	2.3e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HTR7—epilepsy syndrome	1.53e-06	2.29e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ABCG2—epilepsy syndrome	1.52e-06	2.28e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	1.52e-06	2.28e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—SRC—epilepsy syndrome	1.51e-06	2.27e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—KCNJ11—epilepsy syndrome	1.51e-06	2.27e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CHRM3—epilepsy syndrome	1.51e-06	2.27e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	1.51e-06	2.26e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.49e-06	2.23e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.49e-06	2.23e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.49e-06	2.23e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.49e-06	2.23e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.49e-06	2.23e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	1.49e-06	2.22e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HBEGF—epilepsy syndrome	1.48e-06	2.22e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	1.48e-06	2.21e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.47e-06	2.19e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—SRC—epilepsy syndrome	1.46e-06	2.19e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AKT3—epilepsy syndrome	1.46e-06	2.18e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—FGF2—epilepsy syndrome	1.45e-06	2.18e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PRKCB—epilepsy syndrome	1.45e-06	2.17e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6ST—epilepsy syndrome	1.44e-06	2.16e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SLC2A1—epilepsy syndrome	1.44e-06	2.15e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—PRKCB—epilepsy syndrome	1.43e-06	2.14e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—JUNB—epilepsy syndrome	1.43e-06	2.14e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	1.42e-06	2.13e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ADAM10—epilepsy syndrome	1.42e-06	2.13e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS1—epilepsy syndrome	1.42e-06	2.12e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NOS2—epilepsy syndrome	1.41e-06	2.12e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	1.41e-06	2.11e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.41e-06	2.11e-05	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.41e-06	2.11e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TNF—epilepsy syndrome	1.38e-06	2.07e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AQP1—epilepsy syndrome	1.38e-06	2.07e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.38e-06	2.07e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AQP1—epilepsy syndrome	1.37e-06	2.05e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.36e-06	2.04e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.36e-06	2.04e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.36e-06	2.04e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HBEGF—epilepsy syndrome	1.35e-06	2.03e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTGS2—epilepsy syndrome	1.35e-06	2.02e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—RELA—epilepsy syndrome	1.35e-06	2.02e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—S100B—epilepsy syndrome	1.34e-06	2.01e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.34e-06	2e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	1.33e-06	2e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SOCS3—epilepsy syndrome	1.33e-06	1.99e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CDC42—epilepsy syndrome	1.33e-06	1.99e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—AKT3—epilepsy syndrome	1.33e-06	1.99e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—FOS—epilepsy syndrome	1.32e-06	1.98e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MTOR—epilepsy syndrome	1.32e-06	1.98e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.32e-06	1.97e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.31e-06	1.96e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ADAM10—epilepsy syndrome	1.3e-06	1.94e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CASP8—epilepsy syndrome	1.29e-06	1.94e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AVP—epilepsy syndrome	1.29e-06	1.93e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	1.27e-06	1.9e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.27e-06	1.9e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.27e-06	1.9e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—BCHE—epilepsy syndrome	1.26e-06	1.89e-05	CbGpPWpGaD
Celecoxib—CA14—Metabolism—AKT1—epilepsy syndrome	1.25e-06	1.87e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.25e-06	1.87e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.25e-06	1.87e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	1.24e-06	1.85e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	1.24e-06	1.85e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ABCG2—epilepsy syndrome	1.23e-06	1.85e-05	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.23e-06	1.84e-05	CbGpPWpGaD
Celecoxib—CA6—Metabolism—AKT1—epilepsy syndrome	1.22e-06	1.82e-05	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—AKT1—epilepsy syndrome	1.22e-06	1.82e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CASP3—epilepsy syndrome	1.22e-06	1.82e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HES1—epilepsy syndrome	1.22e-06	1.82e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CDC42—epilepsy syndrome	1.21e-06	1.81e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	1.2e-06	1.8e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP2C19—epilepsy syndrome	1.2e-06	1.8e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP11A1—epilepsy syndrome	1.19e-06	1.79e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PLCB1—epilepsy syndrome	1.19e-06	1.78e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.19e-06	1.78e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—TH—epilepsy syndrome	1.19e-06	1.78e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.19e-06	1.78e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—JUN—epilepsy syndrome	1.18e-06	1.77e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—FYN—epilepsy syndrome	1.18e-06	1.77e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—H2AFX—epilepsy syndrome	1.18e-06	1.76e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MEF2C—epilepsy syndrome	1.18e-06	1.76e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—FGF2—epilepsy syndrome	1.17e-06	1.75e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.16e-06	1.74e-05	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—AKT1—epilepsy syndrome	1.15e-06	1.73e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.15e-06	1.73e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MMP9—epilepsy syndrome	1.15e-06	1.72e-05	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—AKT1—epilepsy syndrome	1.14e-06	1.7e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—YWHAZ—epilepsy syndrome	1.14e-06	1.7e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.13e-06	1.69e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.13e-06	1.69e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.13e-06	1.69e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NGF—epilepsy syndrome	1.12e-06	1.68e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—AKT1—epilepsy syndrome	1.12e-06	1.67e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—BCL2—epilepsy syndrome	1.11e-06	1.66e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HES1—epilepsy syndrome	1.11e-06	1.66e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCR5—epilepsy syndrome	1.09e-06	1.64e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—RELA—epilepsy syndrome	1.08e-06	1.62e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—FYN—epilepsy syndrome	1.08e-06	1.61e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP2D6—epilepsy syndrome	1.08e-06	1.61e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.08e-06	1.61e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.08e-06	1.61e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—H2AFX—epilepsy syndrome	1.07e-06	1.61e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HTR2A—epilepsy syndrome	1.07e-06	1.6e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—MTOR—epilepsy syndrome	1.06e-06	1.59e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—SRC—epilepsy syndrome	1.06e-06	1.59e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.05e-06	1.58e-05	CbGpPWpGaD
Celecoxib—CA12—Metabolism—AKT1—epilepsy syndrome	1.05e-06	1.58e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—YWHAZ—epilepsy syndrome	1.04e-06	1.55e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.03e-06	1.55e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—VEGFA—epilepsy syndrome	1.03e-06	1.55e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—AKT1—epilepsy syndrome	1.03e-06	1.54e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ADRA2A—epilepsy syndrome	1.03e-06	1.54e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—BCHE—epilepsy syndrome	1.02e-06	1.53e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—AKT1—epilepsy syndrome	1.02e-06	1.53e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.02e-06	1.52e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TSC2—epilepsy syndrome	1.02e-06	1.52e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AGT—epilepsy syndrome	1.02e-06	1.52e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.01e-06	1.52e-05	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	1.01e-06	1.52e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—AKT1—epilepsy syndrome	1.01e-06	1.51e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.01e-06	1.51e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CCR5—epilepsy syndrome	9.97e-07	1.49e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—APOE—epilepsy syndrome	9.95e-07	1.49e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	9.94e-07	1.49e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	9.92e-07	1.49e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—HMOX1—epilepsy syndrome	9.91e-07	1.48e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	9.86e-07	1.48e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	9.84e-07	1.47e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL1B—epilepsy syndrome	9.81e-07	1.47e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CAT—epilepsy syndrome	9.78e-07	1.46e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	9.78e-07	1.46e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SLC2A1—epilepsy syndrome	9.75e-07	1.46e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—KDR—epilepsy syndrome	9.74e-07	1.46e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.71e-07	1.45e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PLCB1—epilepsy syndrome	9.64e-07	1.44e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—TH—epilepsy syndrome	9.61e-07	1.44e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ABCB1—epilepsy syndrome	9.51e-07	1.42e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—JUN—epilepsy syndrome	9.5e-07	1.42e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.46e-07	1.42e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—AKT1—epilepsy syndrome	9.41e-07	1.41e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PRKCB—epilepsy syndrome	9.38e-07	1.4e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6ST—epilepsy syndrome	9.34e-07	1.4e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	9.3e-07	1.39e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TSC2—epilepsy syndrome	9.27e-07	1.39e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—AKT1—epilepsy syndrome	9.1e-07	1.36e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APOE—epilepsy syndrome	9.07e-07	1.36e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AQP1—epilepsy syndrome	9.03e-07	1.35e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.85e-07	1.33e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GPX1—epilepsy syndrome	8.84e-07	1.32e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	8.82e-07	1.32e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—POMC—epilepsy syndrome	8.54e-07	1.28e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—SRC—epilepsy syndrome	8.52e-07	1.28e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6ST—epilepsy syndrome	8.52e-07	1.28e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	8.47e-07	1.27e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS2—epilepsy syndrome	8.46e-07	1.27e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—BCHE—epilepsy syndrome	8.44e-07	1.26e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—SRC—epilepsy syndrome	8.4e-07	1.26e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—AKT1—epilepsy syndrome	8.4e-07	1.26e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	8.4e-07	1.26e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—BCHE—epilepsy syndrome	8.36e-07	1.25e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCL2—epilepsy syndrome	8.36e-07	1.25e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—VEGFA—epilepsy syndrome	8.18e-07	1.23e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	8.17e-07	1.22e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	8.17e-07	1.22e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—AKT1—epilepsy syndrome	8.05e-07	1.21e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	8.05e-07	1.21e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—HMOX1—epilepsy syndrome	8.02e-07	1.2e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	7.98e-07	1.19e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	7.96e-07	1.19e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—TH—epilepsy syndrome	7.93e-07	1.19e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CAT—epilepsy syndrome	7.91e-07	1.18e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	7.89e-07	1.18e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—TH—epilepsy syndrome	7.86e-07	1.18e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AGT—epilepsy syndrome	7.76e-07	1.16e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.74e-07	1.16e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ABCB1—epilepsy syndrome	7.7e-07	1.15e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—APOE—epilepsy syndrome	7.6e-07	1.14e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—FGF2—epilepsy syndrome	7.56e-07	1.13e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GPX1—epilepsy syndrome	7.16e-07	1.07e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RELA—epilepsy syndrome	7.01e-07	1.05e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—FGF2—epilepsy syndrome	6.89e-07	1.03e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MTOR—epilepsy syndrome	6.88e-07	1.03e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—AKT1—epilepsy syndrome	6.79e-07	1.02e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	6.66e-07	9.97e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	6.62e-07	9.91e-06	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—AKT1—epilepsy syndrome	6.59e-07	9.87e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	6.56e-07	9.83e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CAT—epilepsy syndrome	6.53e-07	9.78e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—POMC—epilepsy syndrome	6.53e-07	9.77e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	6.49e-07	9.71e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CAT—epilepsy syndrome	6.48e-07	9.7e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	6.45e-07	9.65e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	6.35e-07	9.52e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CASP3—epilepsy syndrome	6.33e-07	9.47e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	6.3e-07	9.43e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MTOR—epilepsy syndrome	6.27e-07	9.39e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AGT—epilepsy syndrome	6.27e-07	9.39e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOE—epilepsy syndrome	6.15e-07	9.2e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—JUN—epilepsy syndrome	6.14e-07	9.2e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MMP9—epilepsy syndrome	5.98e-07	8.95e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ALB—epilepsy syndrome	5.95e-07	8.91e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GPX1—epilepsy syndrome	5.91e-07	8.85e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GPX1—epilepsy syndrome	5.86e-07	8.77e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	5.82e-07	8.71e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	5.54e-07	8.29e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—BCHE—epilepsy syndrome	5.52e-07	8.26e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SRC—epilepsy syndrome	5.51e-07	8.25e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VEGFA—epilepsy syndrome	5.37e-07	8.04e-06	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—AKT1—epilepsy syndrome	5.3e-07	7.93e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—POMC—epilepsy syndrome	5.28e-07	7.91e-06	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—AKT1—epilepsy syndrome	5.27e-07	7.89e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	5.26e-07	7.88e-06	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—AKT1—epilepsy syndrome	5.22e-07	7.82e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	5.21e-07	7.79e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TH—epilepsy syndrome	5.19e-07	7.77e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AGT—epilepsy syndrome	5.18e-07	7.76e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AGT—epilepsy syndrome	5.14e-07	7.69e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOE—epilepsy syndrome	5.08e-07	7.6e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOE—epilepsy syndrome	5.03e-07	7.53e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SRC—epilepsy syndrome	5.03e-07	7.53e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—POMC—epilepsy syndrome	4.36e-07	6.53e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	4.33e-07	6.48e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—POMC—epilepsy syndrome	4.32e-07	6.47e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.27e-07	6.4e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS2—epilepsy syndrome	4.21e-07	6.31e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.15e-07	6.22e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ALB—epilepsy syndrome	3.98e-07	5.95e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ALB—epilepsy syndrome	3.94e-07	5.9e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GPX1—epilepsy syndrome	3.86e-07	5.78e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	3.48e-07	5.21e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	3.45e-07	5.16e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AKT1—epilepsy syndrome	3.43e-07	5.13e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.39e-07	5.07e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.32e-07	4.97e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—AKT1—epilepsy syndrome	3.12e-07	4.68e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.85e-07	4.27e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AKT1—epilepsy syndrome	2.62e-07	3.92e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.6e-07	3.89e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.27e-07	3.4e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AKT1—epilepsy syndrome	2.12e-07	3.17e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.75e-07	2.62e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.73e-07	2.59e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.14e-07	1.71e-06	CbGpPWpGaD
